SIRO ClinPharm (SIRO),has entered into pact with oncology drug development service provider Advanced Clinical Trial Solutions LLC (ACT Solutions) of USA.
The Flemington, NJ-based ACT Solutions, which offers services in developing cancer therapeutics, is concentrated in the North American market.
This alliance will enable SIRO to expand its oncology clinical development and patient recruitment expertise to North America. ACT Solutions and its clients will benefit by gaining access to SIRO’s clinical study management, patient recruitment, data management, biostatistics and medical writing capabilities in India and European countries.
“We are delighted to add ACT Solution’s North American expertise in our service offering to our customers, said Dr Chetan Tamhankar, COO of SIRO ClinPharm group. “This alliance is the first step for SIRO in creating delivery capabilities in North America.”
“We are excited about aligning our strengths in oncology with SIRO’s international delivery capabilities,” said Patricia Devitt Risse, president of ACT Solutions LLC. “This step addresses the changing dynamics of the clinical research sector. We remain committed to providing a level of expertise and service that built our reputation and loyal client base to this point and this alliance expands our ability to deliver capabilities in Europe and India,” she explained.
SIRO is a leading contract research organization from India with multinational operations. With a presence in over 15 countries across North America, Europe and Asia, SIRO offers global bio-technology. SIRO offers a range services related to clinical drug development process including feasibility and patient access planning, project management and planning, clinical monitoring, medical services, clinical audit services and quality assurance, site contract management, clinical resourcing, investigator recruitment, CRF design, clinical data management, biostatistics and medical writing.
SIRO ClinPharma acquired 100% stake, in an all cash deal, with the companies within the Omega Mediation Group, a leading mid-sized European CRO.
The acquisition was expected to provide SIRO with operational capabilities in 5 key European Countries and Israel and access to Omega’s clients with major European pharmaceutical and biotech clients.
In early July, 2007 SIRO acquired Global Client Partners (GCP), a US based CRO with strong client networks among the US biotech and pharma companies.
Quite recently, SIRO has set up its office in Princeton, NJ, with an objective to reach strategic customers in North America.
Advanced Clinical Trial Solutions LLC (ACT Solutions) is a privately held company that is devoted to operational excellence in global oncology drug development.